Home  |  Contact

Cellosaurus RPC-9 (CVCL_B263)

[Text version]

Cell line name RPC-9
Synonyms RPC9
Accession CVCL_B263
Resource Identification Initiative To cite this cell line use: RPC-9 (RRID:CVCL_B263)
Comments Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
Sequence variations EGFR p.Glu746_Ala750del (c.2235_2249del15) (from parent cell line).
Homozygous for TP53 p.Arg248Gln (c.743G>A) (from parent cell line).
Disease Lung adenocarcinoma (NCIt: C3512)
Derived from metastatic site: Lymph node.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_B260 (PC-9)
Sex of cell Male
Age at sampling 45Y
Category Cancer cell line

PubMed=17699786; DOI=10.1158/0008-5472.CAN-07-0681
Ogino A., Kitao H., Hirano S., Uchida A., Ishiai M., Kozuki T., Takigawa N., Takata M., Kiura K., Tanimoto M.
Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non small cell lung cancer cell line.
Cancer Res. 67:7807-7814(2007)

Other Wikidata; Q54951132
Polymorphism and mutation databases Cosmic; 1083085
Entry history
Entry creation06-Jun-2012
Last entry updated06-Sep-2019
Version number11